Skip to main content
SpringerLink
Log in

Treatment of Co-occurring Alcohol, Drug, and Psychiatric Disorders

  • Chapter
Recent Developments in Alcoholism

Part of the book series: Recent Developments in Alcoholism ((RDIA,volume 17))

Abstract

Comorbid psychiatric disorders and drug use disorders (DUDs) are common among adolescents with alcohol use disorders (AUDs). These comorbid disorders have a large potential significance on the clinical course of the AUDs among adolescents, and can predict a shorter time to relapse of alcohol use. The use of medication for treatment of the various comorbid adolescent populations has increased dramatically in recent years, despite the lack of double-blind, placebo-controlled studies that demonstrate their safety and efficacy. Consequently, to date, no empirically proven treatment exists for most of these comorbid disorders. This chapter reviews the state of the art regarding the treatment of comorbid adolescents. This chapter also identifies gaps in knowledge regarding the treatment of comorbid adolescents, and outlines directions for future research in this field.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Apsler, R. (1994). Is drug abuse treatment effective? American Enterprise March/April, 46–53.

    Google Scholar 

  • Armentano, M.E., & Solhkhah, R. (2003). Co-occurring disorders in adolescents, In Principles of Addiction Medicine, Third Ed, Section 13, Chapter 8, pp. 1573–1584, 2003.

    Google Scholar 

  • Birmaher, B., Brent, D.A., Kolko, D., Baugher, M., Bridge, J., Holder, D., Iyengar, S., & Uloa, R.E. (2000). Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Archives of General Psychiatry 57, 29–36.

    Article  PubMed  Google Scholar 

  • Birmaher, B., Axelson, D.A., Monk, K., Kalas, C., Clark, D.B., Ehmann, M., Bridge, J., Heo, J., & Brent, D.A. (2003). Flouxetine for the treatment of childhood anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry 42, 415–423.

    PubMed  Google Scholar 

  • Brady, K.T., Halligan, P., & Malcolm, R.J. (1999). Dual diagnosis. In M. Galanter & H.D. Kleber (Eds.), Textbook of Substance Abuse Treatment, 2nd ed., Washington, DC: The American Psychiatric Press, pp. 475–483.

    Google Scholar 

  • Bukstein, O.G., & Cornelius, J. (in press). Psychopharmacology of adolescents with substance use disorders: using diagnostic specific treatments. In H. Liddle & C. Rowe (Eds.) Treating Adolescent Substance Abuse: State of the Science.

    Google Scholar 

  • Bukstein, O.G., & Kaminer, Y. (1994). The nosology of adolescent substance abuse and dependence. Alcohol Health and Research World 18, 296–301.

    Google Scholar 

  • Cannabis Youth Treatment (CYT) Group (2000). Cannabis youth treatment (CYT) experiment: preliminary findings. A report presented to the Center for Substance Abuse Treatment (CSAT). U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Rockville, MD.

    Google Scholar 

  • Christie, K.A., Burke, J.D., Regier, D.A., Rae, D.S., Bod, J.H., & Locke, B.Z. (1988). Epidemiologic evidence for early onset of mental disorders and higher risk of drug abuse in young adults. American Journal of Psychiatry 145, 971–975.

    PubMed  Google Scholar 

  • Clark, D.B., Bukstein, O., & Cornelius, J. (2002). Alcohol use disorders in adolescents: epidemiology, diagnosis, psychosocial interventions, and pharmacological treatment. Pediatric Drugs 4, 493–502.

    PubMed  Google Scholar 

  • Clark, D.B., Bukstein, O.G., Smith, M.G., Kaczynski, N.A., Mezzich, A.C., & Donovan, J.E. (1995). Identifying anxiety disorders in adolescents hospitalized for alcohol abuse or dependence. Psychiatric Services 46, 618–620.

    PubMed  Google Scholar 

  • Clark, D.B., Lesnick, L., & Hegedus, A.M. (1997). Traumas and other adverse events in adolescents with alcohol abuse or dependence. Journal of the American Academy of Child and Adolescent Psychiatry 36, 1744–1751.

    Article  PubMed  Google Scholar 

  • Clark, D.B., Pollock, N.K., Bukstein, O.G., Mezzich, A.C., Bromberger, J.T., & Donovan, J.E. (1997). Gender and comorbid psychopathology in adolescents with alcohol dependence. Journal of the American Academy of Child and Adolescent Psychiatry 36, 1195–1203.

    Article  PubMed  Google Scholar 

  • Clark, D.B, Vanyukov, M., & Cornelius, J. (2002). Childhood antisocial behavior and adolescent alcohol use disorders. Alcohol Research and Health 26, 109–115.

    Google Scholar 

  • Clark, D.B., Wood, D.S., Cornelius, J.R., Bukstein, O.G., & Martin, C.S. (2003). Clinical practices in the pharmacological treatment of comorbid psychopathology in adolescents with alcohol use disorders. Journal of Substance Abuse Treatment. 25:293–295.

    Article  PubMed  Google Scholar 

  • Corby, E.A., Roll, J.M., Ledgerwood, D.M., & Schuster, C.R. (2000). Contingency management interventions for treating the substance abuse of adolescents: a feasibility study. Experimental Clinical Psychopharmacology 8, 371–376.

    Article  Google Scholar 

  • Cornelius, J.R., Bukstein, O.G., Birmaher, I.M., Salloum, I.M., Kelly, T.M., Walters, M.C., Wood, S.D., & Clark, D.B. (2003). Fluoxetine in depressed AUD adolescents: a three-year follow-up evaluation. Alcoholism: Clinical and Experimental Research 27(5) Suppl. 145A.

    Google Scholar 

  • Cornelius, J.R., Bukstein, O.G., Birmaher, B., Salloum, I.M., Lynch, K., Pollock, N.K., Gershon, S., & Clark, D.B. (2001). Fluoxetine in adolescents with major depression and an alcohol use disorder: An open label trial. Addictive Behaviors 26, 735–739.

    Article  PubMed  Google Scholar 

  • Cornelius, J.R., Bukstein, O.G., Salloum, I.M., Kelly, T.M, Wood, D.S., & Clark, D.B. (2004). Fluoxetine in depressed AUD adolescents: a one-year follow-up evaluation. Journal of Child and Adolescent Psychopharmacology. 14:35–40.

    Article  Google Scholar 

  • Cornelius, J.R., Maisto, S.A., Martin, C.S., Bukstein, O.G., Salloum, I.M., Daley, D.C., Wood, D.S., & Clark, D.B. (2004). Major depression associated with earlier alcohol relapse in treated teens with AUD. Addictive Behaviors. 29:1035–1038.

    Article  PubMed  Google Scholar 

  • Deas, D., Riggs, P., Langenbucher, J., Goldman, M., & Brown, S. (2000). Adolescents are not adults: developmental considerations in alcohol users. Alcoholism: Clinical and Experimental Research 24, 232–237.

    Article  Google Scholar 

  • Deas, D., & Thomas, S.E. (2001). An overview of controlled studies of adolescent substance abuse treatment. The American Journal on Addictions 10, 178–189.

    Article  PubMed  Google Scholar 

  • Deas-Nesmith, D., Randall, C., Roberts, J., & Anton, R. (1998). Sertraline treatment of depressed adolescent alcoholics: a pilot study. Alcoholism: Clinical and Experimental Research 22, 74A.

    Google Scholar 

  • Dishion, T.J., McCord, J., & Poulin, F. (1999). When interventions harm: Peer groups and problem behavior. American Psychologist 54(4), 755–764.

    Article  PubMed  Google Scholar 

  • Emslie, G.J. (2002). Second controlled study finds efficacy of fluoxetine in pediatric depression. Brown University Child and Adolescent Psychopharmacology Update 4(12) 1–3.

    Google Scholar 

  • Emslie, G.J., Rush, A.J., Weinberg, W.A., Kowatch, R.A., Hughes, C.W., Carmody, T., & Rintelmann, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 54, 1031–1037.

    PubMed  Google Scholar 

  • Emslie, G.J., Rush, A.J., Weinberg, W.A., Kowatch, R.A., Carmody, T., & Mayes, T.L. (1998). Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depression and Anxiety 7, 32–39.

    Article  PubMed  Google Scholar 

  • Eyre, S.L., Rounsaville, B.J., & Kleber, H.D. (1982). History of childhood hyperactivity in a clinic population of opiate addicts. Journal of Nervous and Mental Disorders 170, 522–529.

    Google Scholar 

  • Fleming, J.E., & Offord, D.R. (1990). Epidemiology of childhood depressive disorders: a critical review. Journal of the American Academy of Child and Adolescent Psychiatry 29, 571–580.

    PubMed  Google Scholar 

  • Food and Drug Administration (FDA) Approvals (2003). Fluoxetine Supplemental NDA. Medscape Pharmacists 4(1), 2.

    Google Scholar 

  • Food and Drug Administration (2004). Worsening depression and suicidality in patients being treated with antidepressant medications. http:/ /www.fda.gov/cder/drug/antidepressants/default.htm

    Google Scholar 

  • Geller, B., Cooper, T.B., Sun, K., Zimerman, B., Frazier, J., Williams, M., & Heath, J. (1999). Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. Journal of the American Academy of Child and Adolescent Psychiatry 37, 171–178.

    Article  Google Scholar 

  • Greenfield, S.F., Weiss, R.D., Muenz, L.R., Vagge, L.M., Kelly, J.F., Bello, L.R., & Michael, J. (1998). The effect of depression on return to drinking. Archives of General Psychiatry 55, 259–265.

    Article  PubMed  Google Scholar 

  • Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995). Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. British Medical Journal 310, 897–901.

    PubMed  Google Scholar 

  • Henggeler, S.W., Clingempeel, W.G., Brondino, M.J., & Pickrel, S.G. (2002). Four-year follow-up of multisystemic therapy with substance-abusing and substance-dependent juvenile offenders. Journal of the American Academy of Child and Adolescent Psychiatry 41, 868–874.

    Article  PubMed  Google Scholar 

  • Hesselbrock, M.N., Meyer, R.E., & Keener, J.J. (1985). Psychopathology in hospitalized alcoholics. Archives of General Psychiatry 42, 1050–1055.

    PubMed  Google Scholar 

  • Hird, S., Khuri, E.T., Dusenbury, L., & Millman, R.B. (1997). Adolescents. In J.H. Lowinson, P. Ruiz, R.B. Milman, & J.G. Langrod (Eds.) Substance Abuse: A Comprehensive Textbook 3rd ed., Williams & Wilkins, Baltimore, pp. 683–692.

    Google Scholar 

  • Hser, Y.I., Grella, C.E., Hubbard, R.L., Hsieh, S.C., Fletcher, B.W., Brown, B.S., & Anglin, D. (2001). An evaluation of drug treatments for adolescents in 4 US cities. Archives of General Psychiatry 58, 689–695.

    Article  PubMed  Google Scholar 

  • Hubbard, R.L., Cavanaugh, E.R., Craddock, S.G., & Rachal, J.V. (1985). Characteristics, behaviors, and outcomes for youth in the TOPS. In A.S. Friedman & G. Beschner (Eds.), Treatment Services for Adolescent Substance Abusers, Rockville, MD: U.S. Department of Health and Human Services, pp. 49–65.

    Google Scholar 

  • Kaminer, Y. (1994). Understanding and Treating Adolescent Substance Abuse. New York: Plenum Press.

    Google Scholar 

  • Kaminer, Y. (1995). Pharmacotherapy for adolescents with psychoactive substance use disorders. In E. Rahdert & D. Czechowicz (Eds.), National Institute of Drug Abuse Research Monograph 156, Adolescent Drug Abuse: Clinical Assessment and Therapeutic Interventions, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Rockville, MD, pp. 291–324.

    Google Scholar 

  • Kaminer, Y. (2002). Adolescent substance abuse treatment: evidence-based practice in outpatient services. Current Psychiatry Reports 4, 397–401.

    PubMed  Google Scholar 

  • Kaminer, Y., Burleson, J.A., Blitz, C., Sussman, J., & Rounsaville, B.J. (1998). Psychotherapies for adolescent substance abusers: a pilot study. Journal of Nervous and Mental Disorders 186, 684–690.

    Article  Google Scholar 

  • Kandel, D.B., Johnson, J.G., Bird, H.R, Canino G., Goodman, S.H., Lahey, B.B., Regier, D.A., & Schwab-Stone, M. (1997). Psychiatric disorders associated with substance use among children and adolescents: findings from the methods for the epidemiology of child and adolescent mental disorders (MECA) study. Journal of Abnormal Child Psychology 25, 121–132.

    Article  PubMed  Google Scholar 

  • Keller, M.B., Ryan, N.D., Strober, M., Klein, R.G., Stan, K., Birmaher, B., Hagino, O., Koplewicz, H., Carlson, G., Clarke, G., Emslie, G., Feinberg, D., Geller, B., Kusumakar, V., Papatheodoro, G., Wagner, K.D., Weller, E.B., Winters, N.C., Oakes, R., & McCafferty, J.P. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry 40, 762–772.

    Article  PubMed  Google Scholar 

  • Kessler, R.C., Crum, R.M., Warner, L.A., Nelson, C.B., Schulenberg, J., & Anthony, J.C. (1997). Life-time co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Archives of General Psychiatry 54, 313–321.

    PubMed  Google Scholar 

  • Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H.U., & Kendler, K.S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8–19.

    PubMed  Google Scholar 

  • Kessler, R.C., & Walters, E.E. (1998). Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the national comorbidity survey. Depression and Anxiety 7, 3–14.

    Article  PubMed  Google Scholar 

  • Khantzian, E.J. (1983). An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. American Journal of Psychiatry 140, 784–785.

    PubMed  Google Scholar 

  • King, G.R., & Ellinwood, E.H. (1997). Amphetamines and other stimulants. In J.H. Lowinson, P. Ruiz, R.B. Milman, & J.G. Langrod (Eds.) Substance Abuse: A Comprehensive Textbook 3rd ed. Baltimore: Williams & Wilkins, pp. 207–223.

    Google Scholar 

  • Klein, R.G., & Mannuzza, S. (1991). Long-term outcome of hyperactive children: a review. Journal of the American Academy of Child and Adolescent Psychiatry 30, 383–387.

    PubMed  Google Scholar 

  • Kroenke, K, West, S.L., Swindle, R., Gilsenan, A., Eckert, G.J., Dolor, R., Stang, P., Zhou, X., Hays, R., & Weinberger, M. (2001). Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial. Journal of the American Medical Association 286, 2947–2955.

    Article  PubMed  Google Scholar 

  • Kuperman, S., Schlosser, S.S., Kramer, J.R., Bucholz, K., Hesselbrock, V., Reich, T., & Reich, W. (2001). Developmental sequence from disruptive behavior diagnosis to adolescent alcohol dependence. American Journal of Psychiatry 158, 2022–2026.

    Article  PubMed  Google Scholar 

  • Levin, F.R., Sullivan, M.A., Donovan, S.J. (2003). Co-occurring addictive and attention deficit/hyperactivity disorder and eating disorder. In A.W. Graham, T.K. Schultz, M.F. Mayo-Smith, R.K. Ries, & B.B. Wilford (Eds.), Principles of Addiction Medicine, Third Edition, American Society of Addiction Medicine, Inc., Chevy Chase, MD, pp. 1321–1346.

    Google Scholar 

  • Lewis, D.O (1996). Conduct disorder. In M. Lewis (Ed.), Child and Adolescent Psychiatry: A Comprehensive Textbook, Second Edition, Williams & Wilkins, Baltimore, MD, pp. 564–574.

    Google Scholar 

  • Litten, R.Z., & Allen, J.P. (1995). Pharmacotherapy for alcoholics with collateral depression or anxiety: An update of research findings. Experimental and Clinical Psychopharmacology 3, 87–93.

    Article  Google Scholar 

  • Liddle, H.A., Dakof, G.A., Parker, K., Diamond, G.S., Barrett, K., & Jejeda, M. (2001). Multidimensional family therapy for adolescent drug abuse: results of a randomized clinical trial. American Journal of Drug and Alcohol Abuse 27, 651–687.

    Article  PubMed  Google Scholar 

  • Mannuzza, S., & Klein, R.G. (2000). Long-term prognosis in attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America 9(3), 711–726.

    PubMed  Google Scholar 

  • Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, ER., Spencer, T., & The Atomoxetine ADHD Study Group (2001). Atomoxetine in the treatment of children and adolescents with ADHD: a randomized, placebo-controlled, dose-response study. Pediatrics 108, e83.

    Article  PubMed  Google Scholar 

  • Miller, W.R., Zweben, A., DiClemente, C.C., & Rychtarik, R.G. (1992). Motivational Enhancement Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence. NIAAA Project MATCH Monograph Series, Volume 2, Editor: Margaret E. Mattson, Ph.D., U.S. Department of Health and Human Services, Public Health Service, NIH.

    Google Scholar 

  • National Opinion Research Center (1997). National Treatment Improvement Evaluation Study, Final Report. Rockville, MD: Center for Substance Abuse and Treatment, US Department of Health and Human Services.

    Google Scholar 

  • Pendergast, M.., Podus, D., Chang, E., & Urada, D. (2002). The effectiveness of drug abuse treatment: A meta-analysis of comparison group studies. Drug and Alcohol Dependence 67, 53–72.

    Article  Google Scholar 

  • Poulin, F., Dishion, T.J, & Burraston, B. (2001). 3-year iatrogenic effects associated with aggregating high-risk adolescents in cognitive-behavioral preventive interventions. Applied Development Science 5(4), 214–224.

    Article  Google Scholar 

  • Regier, D.A., Farmer, M.E., Rae, D.E., Locke, B.Z., Keith, E.J., Judd, L.L., & Goodwin, F.K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association 264, 2511–2518.

    Article  PubMed  Google Scholar 

  • Riggs, P.D., Mikulich, S.K., Coffman, L.M., & Crowley, T.J. (1997). Fluoxetine in drug-dependent delinquents with major depression: An open trial. Journal of Child and Adolescent Psychopharmacology 7, 87–95.

    Article  PubMed  Google Scholar 

  • Riggs, P.D., Mikulich, S.K., & Hall, S.K. (2001). Effects of pemoline on ADHD, antisocial behaviors, and substance use in adolescents with conduct disorder and substance use disorder. Drug and Alcohol Dependence 63, S131.

    Article  Google Scholar 

  • Rohde, P., Lewinsohn, P.M., & Seeley, J.R. (1991). Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults. Journal of Abnormal Psychology 100, 214–221.

    Article  PubMed  Google Scholar 

  • Rosack, J. (2003). FDA warns of suicide risk with paroxetine. Psychiatric News 38,1, 37.

    Google Scholar 

  • Sells, S.B., & Simpson, D.D. (1979). Evaluation of treatment outcome for youths in the Drug-Abuse Reporting Program (DARP): a follow-up study. In G.M. Beschner & A.S. Friedman (eds.) Youth Drug Abuse: Problems, Issues, and Treatment. Lexington Books, Lexington, MA, pp. 571–628.

    Google Scholar 

  • Szatmari, P. (1992). The epidemiology of attention deficit hyperactivity disorder. In G. Weiss (ed.) Child and Adolescent Psychiatric Clinics of North America. Philadelphia, PA: W.B. Saunders, pp. 361–384.

    Google Scholar 

  • Szatmari, P., Offord, D.R., & Boyle, M.N. (1989). Ontario child health study: Prevalence of attention deficit disorder with hyperactivity. Journal of Child Psychology and Psychiatry 30, 205–218.

    PubMed  Google Scholar 

  • Varley, C.K., (2001). Sudden death related to selected tricyclic antidepressants in children: epidemiology, mechanisms, and clinical implications. Paediatric Drugs 3, 613–627.

    Article  PubMed  Google Scholar 

  • Wagner, E.F., Brown, S.A., Monti, P.M., Myers, M.G., & Waldron, H.B. (1999). Innovations in adolescent substance abuse intervention. Alcoholism: Clinical and Experimental Research 23, 236–249.

    Google Scholar 

  • Wagner, K.D., Ambrosini, P., Rynn, M., Wohlberg, C., Yang, R., Greenbaum, M.S., Childress, A., Donnelly, C., & Deas, D. (2003). Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. Journal of the American Medical Association 290, 1033–1041.

    Article  PubMed  Google Scholar 

  • Waldron, H.B., Slesnick, N., Turner, C.W., Brody, J.L., & Peterson, T.R. (2001). Treatment outcomes for adolescent substance abuse at 4-and 7-month assessments. Journal of Consulting and Clinical Psychology 69, 802–813.

    Article  PubMed  Google Scholar 

  • Weiss, G. (1996). Attention deficit hyperactivity disorder. In M. Lewis (ed.) Child and Adolescent Psychiatry: A Comprehensive Textbook, 2nd Ed. Baltimore: Williams & Wilkins, pp. 544–563.

    Google Scholar 

  • Winters, K.C., Stinchfield, R.D., & Opland, E. (2000). The effectiveness of the Minnesota Model approach in the treatment of adolescent drug abusers. Addiction 95, 601–612.

    Article  PubMed  Google Scholar 

  • Wood, D., Wender, P.H., & Reimherr, F.W. (1983). The prevalence of attention deficit disorder, residual type, or minimal drain dysfunction, in a population of male alcoholic patients. American Journal of Psychiatry l40, 95–98.

    Google Scholar 

  • Zito, J.M., Safer, D.J., DosReis, S., Gardner, J.F., Soeken, K., Boles, M., & Lynch, F. (2002). Rising prevalence of antidepressants among US youth. Pediatrics 109, 721–727.

    Article  PubMed  Google Scholar 

  • Zito, J.M., Safer, D.J., DosReis, S., Gardner, J.F., Magder, L., Soeken, K., Boles, M., Lynch, F., & Little, M.A. (2003). Psychotropic practice patterns for youth: a 10-year perspective. Archives of Pediatric and Adolescent Medicine 157, 17–25.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213-2593

    Jack R. Cornelius, Duncan B. Clark, Oscar G. Bukstein & Ihsan M. Salloum

Authors
  1. Jack R. Cornelius
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Duncan B. Clark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Oscar G. Bukstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ihsan M. Salloum
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. New York University School of Medicine, New York, New York

    Marc Galanter

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Kluwer Academic/Plenum Publishers

About this chapter

Cite this chapter

Cornelius, J.R., Clark, D.B., Bukstein, O.G., Salloum, I.M. (2005). Treatment of Co-occurring Alcohol, Drug, and Psychiatric Disorders. In: Galanter, M., Lowman, C., Boyd, G.M., Faden, V.B., Witt, E., Lagressa, D. (eds) Recent Developments in Alcoholism. Recent Developments in Alcoholism, vol 17. Springer, Boston, MA. https://doi.org/10.1007/0-306-48626-1_16

Download citation

Publish with us

Policies and ethics

Search

Navigation